There have been attempts made to develop drugs that act on multiple PPARs including PPARα, PPARγ, and PPARδ for treating metabolic diseases (Dandona et al., 2005; Bianchi et al., 2007; Jain et al., 2018). This evidence concerns the gene PPARG and metabolic disease.